Liver Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged between 18 and 65 years old
- People who have been diagnosed with a long-term hepatitis B infection, confirmed by positive blood test results for more than 6 months
- People who have been diagnosed with liver cancer and have been treated with immune checkpoint inhibitor medicines, with the last dose given within the past 3 months
- People whose hepatitis B virus levels in the blood are relatively low (below 2000 IU/mL)
- People whose liver enzyme and bilirubin levels in the blood are significantly elevated above the normal range (confirm with trial site for exact values)
- People whose blood clotting test result (called INR) is above 1.5, indicating reduced clotting ability
- People whose platelet count in the blood is above a certain level (50 x 10⁹/L)
- People who do not have blocked bile ducts inside the liver caused by tumour growth
Who may not be able to join:
- People who have other active liver diseases
- People who have another type of cancer (other than the liver cancer being treated)
- People who are pregnant or breastfeeding
- People who have HIV infection or a condition where the immune system does not work properly from birth
- People who have severe diabetes, autoimmune diseases, unstable heart or brain blood vessel conditions, significant problems with other major organs, or who have had an organ transplant
- People who have active bleeding, blood clotting disorders affecting the whole body, or blood clot-related conditions
- People who received artificial liver support treatment within one week before joining the trial
- People who would not be able to attend follow-up appointments
- People whom the trial investigator considers unsuitable for participation for other reasons (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Wenxiong Xu, Doctor, Third Affiliated Hospital, Sun Yat-Sen University
Phone: +8613760783281
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Mortality rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.